Published on : Mar 22, 2019
Albany, New York, March 22, 2019: Anticoagulants have been the mainstay of therapy for the long-term and acute prevention and treatment of various types of thromboembolic disorders. The prevention of thromboembolic stroke among patients with persistent atrial fibrillation (AF) has been one of the main indications for oral anticoagulation therapy. At least 2.6 million people are living with atrial fibrillation, and it is estimated to reach 12 million people by the year 2050, states American Heath Health Association.
Additionally, anticoagulants are indicated in, and are firmly prescribed for the prevention and treatment of venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT). As such, unfractionated heparin, vitamin K antagonists (such as warfarin), direct thrombin inhibitors (such as dabigatran and argatroban) and factor Xa inhibitors (e.g., fondaparinux, apixaban and rivaroxaban) become crucial for the prevention and treatment of these disorders. These actionable insights are in line with the report, titled, “Anticoagulants Market—Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026,” which has been freshly incorporated in Market Research Hub’s (MRH) ever-expanding repository.
The introduction of novel oral anticoagulants (NOACs) to the anticoagulants market have attenuated a few of the health care system burdens linked with outpatient warfarin management. NOACs are efficacious as compared to the conventional therapies such as warfarin, which is anticipated to propel the growth of anticoagulants market.
Anticoagulants Market: Report Content
This report presents a robust analysis on anticoagulants market with the support of quantitative and qualitative analysis. The report reveals the dynamics of the market, including drivers, trends, opportunities, and restraints which have significant influence in the development of the market. The report also includes segregation of the market to offer an in-depth analysis of the anticoagulants.
The report elucidates executive summary followed by market overview section. The anticoagulants market overview section deals with value chain analysis, key trend analysis and Porters’ Five Force Analysis. Porters’ Five Force Analysis gives insights on competitive scenario of the market. The report also includes the market attractiveness analysis along with market outlook. The report also includes pricing analysis and market volume projections. Further, the report provides holistic approach on consumer behavior analysis and major distributors’ lists.
The report peruses on competitive scenario of the anticoagulants market. The report sheds light on company overview, financial overview, strategies, recent development and product portfolio.
Anticoagulants Market: Research Methodology
The assessment in the report is backed up by primary sources, incorporating an unbiased and veracious views of seasoned analyst, surveys, interviews, interactions in person and assessment by experts. Additionally, the report is bolstered by secondary sources encompassing verified paid source, trade journals and resourceful database. The report is also propelled by absolute dollar opportunity analysis which significant impact in furthering the development of the anticoagulants market.
Request a Sample with TOC in a PDF format : https://www.marketresearchhub.com/enquiry.php?type=S&repid=2178149
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients .
For Enquiries, Call :
+1-800-998-4852US Toll Free
Email : firstname.lastname@example.org